Evidence map›Paper›PMID 30228180›Full record

ArticleThe Journal of biological chemistry2018

The long noncoding RNA

Wenting Pan, Nasha Zhang, Wenjuan Liu, Jibing Liu, Liqing Zhou, Yang Liu, Ming Yang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Review
  3. LncRNAFrontiers in endocrinology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. NClinical and translational medicine · 2022
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Role of hypermethylated-lncRNAs in the prognosis of bladder cancer patients.The Journal of international medical research · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Insight Into Chromatin-Enriched RNA: A Key Chromatin Regulator in Tumors.Frontiers in cell and developmental biology · 2021
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Wenting PanFrom the College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100096, China.
Nasha Zhangthe Shandong Provincial Key Laboratory of Radiation Oncology, Cancer Research Center, Shandong Cancer Hospital affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, Shandong Province 250117, China, and.
Wenjuan Liuthe Shandong Provincial Key Laboratory of Radiation Oncology, Cancer Research Center, Shandong Cancer Hospital affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, Shandong Province 250117, China, and.
Jibing Liuthe Shandong Provincial Key Laboratory of Radiation Oncology, Cancer Research Center, Shandong Cancer Hospital affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, Shandong Province 250117, China, and.
Liqing Zhouthe Department of Radiation Oncology, Huaian No. 2 Hospital, Huaian 223002, Jiangsu Province, China.
Yang Liuthe Shandong Provincial Key Laboratory of Radiation Oncology, Cancer Research Center, Shandong Cancer Hospital affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, Shandong Province 250117, China, and.
Ming Yangthe Shandong Provincial Key Laboratory of Radiation Oncology, Cancer Research Center, Shandong Cancer Hospital affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, Shandong Province 250117, China, and aaryoung@yeah.net.
Shandong University · CNShandong First Medical University · CNHuaian First People’s Hospital · CNShandong Tumor Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long noncoding RNAs (lncRNAs) are vital players in cancers, including hepatocellular carcinoma (HCC). We previously identified an lncRNA,

Indexed as

AnimalsCarcinogenesisCarcinoma, HepatocellularCell Line, TumorCell Transformation, NeoplasticCpG IslandsCytoskeletal ProteinsDNA MethylationEpigenesis, GeneticGene Expression Regulation, NeoplasticHumansLiver NeoplasmsMaleMiceMice, Inbred BALB CMice, NudeCytoskeletal ProteinsGAS8 protein, humanNeoplasm ProteinsRNA, Long NoncodingapoptosisepigeneticsGAS8GAS8-AS1hepatocellular carcinomahistone modificationlong noncoding RNA (long ncRNA, lncRNA)MLL1tumor suppressor geneWDR5

Identifiers

PMID30228180
PMCPMC6222094
OpenAlexW2891391803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.